|
Pediatric Normative Markerless Movement Analysis
RECRUITINGSponsored by MultiCare Health System Research Institute
Actively Recruiting
SponsorMultiCare Health System Research Institute
Started2024-03-01
Est. completion2027-12
Eligibility
Age3 Years – 25 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06249880
Summary
The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.
Eligibility
Age: 3 Years – 25 YearsHealthy volunteers accepted
Inclusion Criteria: * Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion). * Ambulate independently and without the use of assistive devices or orthoses. * Willing and interested in participating. Exclusion Criteria: * Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues. * Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity. * Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment. * History of premature birth. * Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.
Conditions3
AdolescentCancerPediatric ALL
Locations1 site
Mary Bridge Children's Therapy Unit - Research & Movement Lab
Puyallup, Washington, 98372
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorMultiCare Health System Research Institute
Started2024-03-01
Est. completion2027-12
Eligibility
Age3 Years – 25 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06249880